Prognostic Impacts of β-Blockers in Acute Coronary Syndrome Patients without Heart Failure Treated by Percutaneous Coronary Intervention.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacological research"
DOI: 10.1016/j.phrs.2021.105614
Abstract: BACKGROUND The use of β-blockers for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, and lacks of evidence in the era of reperfusion and intensive secondary preventions. This study aimed to investigate… read more here.
Keywords: analysis; impacts blockers; acute coronary; prognostic impacts ... See more keywords
Neuromuscular Blockers in Acute Respiratory Distress Syndrome: Flat Dose or Not. Are We Missing the Point?
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care Medicine"
DOI: 10.1097/ccm.0000000000004280
Abstract: e438 www.ccmjournal.org May 2020 • Volume 48 • Number 5 2. Lederer DJ, Bell SC, Branson RD, et al: Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors… read more here.
Keywords: care; distress syndrome; acute respiratory; neuromuscular blockers ... See more keywords